U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 211155

Expand all

COPIKTRA (DUVELISIB)
15MG
Marketing Status: Prescription
Active Ingredient: DUVELISIB
Proprietary Name: COPIKTRA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 15MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N211155
Product Number: 001
Approval Date: Sep 24, 2018
Applicant Holder Full Name: SECURA BIO INC
Marketing Status:  Prescription
Patent and Exclusivity Information
COPIKTRA (DUVELISIB)
25MG
Marketing Status: Prescription
Active Ingredient: DUVELISIB
Proprietary Name: COPIKTRA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 25MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N211155
Product Number: 002
Approval Date: Sep 24, 2018
Applicant Holder Full Name: SECURA BIO INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top